Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,290.00 JPY | +1.32% | +0.99% | -0.49% |
Chart calendar Hisamitsu Pharmaceutical Co., Inc.
Upcoming events on Hisamitsu Pharmaceutical Co., Inc.
Past events on Hisamitsu Pharmaceutical Co., Inc.
2024-10-09 | Q2 2025 Earnings Release |
2024-10-09 | Q2 2024 Earnings Release |
2024-08-28 | Détachement de for dividende intermédiaire |
2024-08-28 | Anniversary bonus dividend |
2024-07-10 | Q1 2025 Earnings Release |
2024-05-22 09:00 pm | Annual General Meeting |
2024-04-10 | Q4 2024 Earnings Call |
2024-04-10 | Q4 2024 Earnings Release |
2024-02-27 | Final dividend |
2024-01-10 | Q3 2024 Earnings Release |
2023-10-05 | Q2 2023 Earnings Release |
2023-08-29 | Détachement de for dividende intermédiaire |
2023-07-12 | Q1 2023 Earnings Release |
2023-05-24 09:00 pm | Annual General Meeting |
2023-04-12 | Q4 2023 Earnings Release |
2023-02-26 | Final dividend |
2023-02-26 | Anniversary bonus dividend |
2023-01-11 | Q3 2023 Earnings Release |
2022-10-11 | Interim 2023 Earnings Release |
2022-08-29 | Détachement de for dividende intermédiaire |
Past dividends on Hisamitsu Pharmaceutical Co., Inc.
2024-08-28 | Bonus Payment 2 JPY |
2024-08-28 | Interim Payment 43 JPY |
2024-02-27 | Final Payment 42.5 JPY |
2023-08-29 | Interim Payment 42.5 JPY |
2023-02-26 | Final Payment 42.25 JPY |
2022-08-29 | Interim Payment 42.25 JPY |
2022-02-24 | Final Payment 42 JPY |
2021-08-29 | Interim Payment 42 JPY |
2021-02-24 | Final Payment 41.75 JPY |
2020-08-27 | Interim Payment 41.75 JPY |
2020-02-26 | Final Payment 41.5 JPY |
2019-08-28 | Interim Payment 41.5 JPY |
2019-02-25 | Final Payment 41.25 JPY |
2018-08-28 | Interim Payment 41.25 JPY |
2018-02-25 | Final Payment 41 JPY |
2017-08-28 | Interim Payment 41 JPY |
2017-02-23 | Final Payment 41 JPY |
2016-08-28 | Interim Payment 40.5 JPY |
2016-02-24 | Bonus Payment 1 JPY |
2016-02-24 | Final Payment 40 JPY |
Annual results
Fiscal Period | February | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 120 193 123 000 -2.28% | 128 330 128 000 0.26% | 141 706 142 500 -0.56% | 154 500 | 157 500 | 165 000 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
EBIT Million JPY | Released Forecast Spread | 9 337 9 400 -0.67% | 11 599 12 000 -3.34% | 13 167 15 600 -15.6% | 16 600 | 16 800 | 21 100 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 12 956 12 600 2.83% | 16 113 17 300 -6.86% | 19 186 21 000 -8.64% | 23 800 | 22 000 | 26 300 |
Net income Million JPY | Released Forecast Spread | 9 658 8 800 9.75% | 11 742 12 900 -8.98% | 13 969 15 300 -8.7% | 17 200 | 15 900 | 19 200 |
EPS JPY | Released Forecast Spread | 119 110 7.82% | 148 164 -9.64% | 182 199 -8.9% | 231 | 220 | 273 |
Announcement Date | 07/04/22 | 13/04/23 | 11/04/24 | - |
Quarterly results
Fiscal Period | August | 2024 Q1 | 2024 S1 | 2024 Q3 | 2025 Q1 | 2025 S1 | 2026 Q1 | 2026 S1 | 2027 Q1 | 2027 S1 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 32 096 31 000 3.54% | 66 977 66 000 1.48% | 35 850 | 35 810 36 500 -1.89% | 75 456 76 500 -1.36% | 37 000 | 76 500 | 38 500 | 79 000 |
EBIT Million JPY | Released Forecast Spread | 4 361 1 900 129.53% | 8 396 8 200 2.39% | 3 874 | 4 149 3 400 22.03% | 9 006 7 800 15.46% | 4 300 | 9 500 | 4 800 | 10 700 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 5 712 | 11 638 | 5 021 | 6 915 4 000 72.88% | 13 101 | ||||
Net income Million JPY | Released Forecast Spread | 4 049 1 500 169.93% | 8 417 7 100 18.55% | 3 693 | 4 788 3 300 45.09% | 9 098 8 400 8.31% | 3 700 | 8 300 | 4 300 | 9 500 |
EPS JPY | Released Forecast Spread | 52,1 19,4 168.51% | 108 92,5 17.12% | 48,3 | 63,9 43,6 46.54% | 123 113 8.88% | 49,6 | 101 | 59,4 | 117 |
Announcement Date | 13/07/23 | 06/10/23 | 11/01/24 | 11/07/24 | 10/10/24 | - | - | - | - |
Past sector events for Hisamitsu Pharmaceutical Co., Inc.
2024-11-28 | DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release |
2024-11-15 01:38 am | BAVARIAN NORDIC A/S: Q3 2024 Earnings Release |
2024-11-14 11:01 pm | CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release |
2024-11-14 09:03 am | GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release |
2024-11-14 07:00 am | OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release |
2024-11-14 02:49 am | IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release |
2024-11-14 01:30 am | DERMAPHARM HOLDING SE: Q3 2024 Earnings Release |
2024-11-14 01:30 am | ALK-ABELLÓ A/S: Q3 2024 Earnings Release |
2024-11-13 | DONGKOOK PHARMACEUTICAL CO., LTD.: Q3 2024 Earnings Release |
2024-11-13 | HANALL BIOPHARMA CO., LTD.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4530 Stock
- Calendar Hisamitsu Pharmaceutical Co., Inc.